INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo GURONSAN C (Effervescent Tablets)
SCHEDULING STATUS:
Not scheduled

PROPRIETARY NAME
(and dosage form):

GURONSAN C (Effervescent Tablets)

COMPOSITION:
Each tablet contains:
Caffeine50,0 mg
Ascorbic Acid300,0 mg 500% RDA per tablet*
Glucuronolactone50,0 mg
*RDA = Recommended Daily Dietary Allowance

PHARMACOLOGICAL CLASSIFICATION:
Complementary Medicine

INDICATIONS:
Guronsan Cis an effervescent formulation containing energy enhancing ingredients and ascorbic acid (vitamin C) to assist the body in overcoming fatigue and lack of vitality.

CONTRA-INDICATIONS:
Guronsan Cis contra-indicated in patients with hyperoxaluria, peptic ulceration, hyperthyroidism,hypertension, cardiac arrhythmias, or other cardiovascular disease, uncontrolledseizure disorders, insomnia and anxiety disorders as these may be exacerbated.

DOSAGE AND DIRECTIONS FOR USE:
One tablet to be taken daily. Drop the tablet in half a glass of water. The tablet quickly dissolves producing a good-tasting, effervescent drink. Cold water is recommendedfor a more pleasant taste. Drink the mixture as soon as the tablet is dissolved.

SIDE EFFECTS AND SPECIAL PRECAUTIONS:
Glucuronolactone
No known side-effects have been reported.
Ascorbic Acid (Vitamin C)
Large doses may cause diarrhoea, other gastro-intestinal disturbances.
Caffeine
Gastro-intestinal irritation including nausea, vomiting, abdominal pain,diarrhoea and gastrointestinal bleeding. Insomnia, headache, anxiety, restlessness, dizziness and palpitations.

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
Glucuronolactone:
Treatment is supportive and symptomatic.
Ascorbic Acid:
Diarrhoea or other gastro-intestinal disturbances.
Treatment is supportive and symptomatic.
Caffeine:
Overdosage or idiosyncrasy may lead to agitation, anxiety, confusion, delirium and convulsions. Headache, vomiting, dehydration, fever, tinnitus and urinary frequency may occur. Severe toxicity may not be preceded by milder symptoms.
Treatment
In cases of overdosage, consult a doctor immediately. Treatment is supportive and symptomatic.

IDENTIFICATION:
A round, flat pale yellow bisected tablet with bevelled edges. A logo and letters “C S K”appear engraved on one side.

PRESENTATION:
Polypropylene tubes containing 10 tablets.

STORAGE INSTRUCTIONS:
Since the tablets are not to absorb moisture, the containershould be sealed tightly after each use and kept in a dry place. Store below 25ºC.
KEEP OUT OF REACH OF CHILDREN.

NAME AND BUSINESS ADDRESS OF THE APPLICANT:
PHARMACARE LIMITED
Building 12,
Healthcare Park,
Woodlands Drive,
Woodmead,
2191

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
22 May 2009

Manufactured under licence from: Lion Corporation, Japan

Updated on this site: June 2010
Source: Pharmaceutical Industry

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2010